Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease
Long M, Parlett L, Lewis J, Haynes K, Adimadhyam S, Hou L, Wolfe A, Toh S, Burris J, Dorand J, Kappelman M. Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2023, 30: 1345-1352. PMID: 37611117, DOI: 10.1093/ibd/izad176.Peer-Reviewed Original ResearchInflammatory bowel diseaseAnti-tumor necrosis factor α therapyCOVID-19 complicationsMechanical ventilationBowel diseaseΑ therapyCOVID-19Users of corticosteroidsRetrospective cohort studyIncidence of hospitalizationCOVID-19 hospitalizationOutcomes of interestIBD medicationsIBD patientsOutpatient deathsCohort studyInpatient deathMedication utilizationMore hospitalizationsDecreased riskImmunosuppressed individualsMean ageTreatment codesLarge cohortCorticosteroids
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply